comparemela.com

Latest Breaking News On - Aramis trial - Page 1 : comparemela.com

Treatment Options for Nonmetastatic CRPC

Rashid K. Sayyid, MD, MSc, gives a brief overview of treatment options for nonmetastatic castrate-resistant prostate cancer.

Prostate cancer treatment landscapeProstate cancerNonmetastatic castrate resistant prostate cancerNonmetastatic crpcAndrogen deprivation therapyAramis trialSpartan trialProsper trial

Extended Darolutamide Demonstrates Long-term Safety, Clinical Benefit in Nonmetastatic CRPC

Darolutamide given in an extended duration was linked with long-term clinical benefit and safety in patients with nonmetastatic castration-resistant prostate cancer.

United statesDarolutamide nubeqaCarolina urologic research centerCastration resistant prostate cancerProstate cancerAramis trialAramis rollover studyNeald shoreAua annual meeting

Importance of Quality of Life When Choosing Therapy for nmCRPC

A brief discussion on the role of quality of life in selecting best therapy for patients with non-metastatic castration-resistant prostate cancer.

Key updatesMetastatic prostate cancer treatmentLife when choosing therapyProstate cancerNonmetastatic castration resistant prostate cancerAr inhibitorsAndrogen receptor inhibitorsQuality of lifeQol dataSpartan trialSpartan studyProsper trialProsper studyAramis trialAramis study

AR Inhibitors in nmCRPC: Real-World Data

Key opinion leaders reflect on the real-world use and data behind AR inhibitors in non-metastatic castration-resistant prostate cancer.

Key updatesMetastatic prostate cancer treatmentReal world dataProstate cancerNonmetastatic castration resistant prostate cancerAr inhibitorsAndrogen receptor inhibitorsDear studyDear trialSpartan trialSpartan studyProsper trialProsper studyAramis trialAramis study

nmCRPC: Clinical Trial Data on AR Inhibitors

Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.

Key updatesMetastatic prostate cancer treatmentClinical trial dataProstate cancerNonmetastatic castration resistant prostate cancerSpartan trialSpartan studyProsper trialProsper studyAramis trialAramis studyMetastasis free survivalMfs survivalOverall survivalSurvival dataAr inhibitors

vimarsana © 2020. All Rights Reserved.